ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 1,918 | 1,923 | 1,908 | 1,917 | +17 | +0.9% | 70,800 |
2021/01/06 | 1,903 | 1,913 | 1,896 | 1,900 | -8 | -0.4% | 89,400 |
2021/01/05 | 1,898 | 1,914 | 1,889 | 1,908 | +10 | +0.5% | 92,700 |
2021/01/04 | 1,891 | 1,906 | 1,870 | 1,898 | -3 | -0.2% | 66,400 |
2020/12/30 | 1,918 | 1,918 | 1,896 | 1,901 | -27 | -1.4% | 38,300 |
2020/12/29 | 1,918 | 1,928 | 1,903 | 1,928 | +21 | +1.1% | 48,000 |
2020/12/28 | 1,915 | 1,927 | 1,898 | 1,907 | -4 | -0.2% | 53,000 |
2020/12/25 | 1,918 | 1,918 | 1,903 | 1,911 | +7 | +0.4% | 58,800 |
2020/12/24 | 1,906 | 1,910 | 1,892 | 1,904 | +3 | +0.2% | 68,700 |
2020/12/23 | 1,905 | 1,911 | 1,894 | 1,901 | +6 | +0.3% | 91,200 |
2020/12/22 | 1,911 | 1,911 | 1,894 | 1,895 | -16 | -0.8% | 57,300 |
2020/12/21 | 1,910 | 1,917 | 1,894 | 1,911 | -3 | -0.2% | 34,400 |
2020/12/18 | 1,901 | 1,914 | 1,895 | 1,914 | +13 | +0.7% | 54,200 |
2020/12/17 | 1,904 | 1,912 | 1,890 | 1,901 | +2 | +0.1% | 66,100 |
2020/12/16 | 1,917 | 1,918 | 1,899 | 1,899 | -14 | -0.7% | 72,500 |
2020/12/15 | 1,913 | 1,933 | 1,910 | 1,913 | -18 | -0.9% | 39,700 |
2020/12/14 | 1,921 | 1,948 | 1,915 | 1,931 | +11 | +0.6% | 50,500 |
2020/12/11 | 1,911 | 1,923 | 1,900 | 1,920 | +3 | +0.2% | 76,500 |
2020/12/10 | 1,918 | 1,918 | 1,905 | 1,917 | -1 | -0.1% | 27,600 |
2020/12/09 | 1,902 | 1,918 | 1,896 | 1,918 | +22 | +1.2% | 32,500 |
2020/12/08 | 1,878 | 1,905 | 1,862 | 1,896 | +11 | +0.6% | 62,200 |
2020/12/07 | 1,862 | 1,891 | 1,860 | 1,885 | +8 | +0.4% | 84,200 |
2020/12/04 | 1,854 | 1,879 | 1,851 | 1,877 | +23 | +1.2% | 57,400 |
2020/12/03 | 1,870 | 1,883 | 1,848 | 1,854 | -21 | -1.1% | 68,500 |
2020/12/02 | 1,878 | 1,891 | 1,865 | 1,875 | -3 | -0.2% | 101,400 |
2020/12/01 | 1,872 | 1,899 | 1,856 | 1,878 | +10 | +0.5% | 57,000 |
2020/11/30 | 1,960 | 1,960 | 1,868 | 1,868 | -64 | -3.3% | 98,500 |
2020/11/27 | 1,899 | 1,950 | 1,895 | 1,932 | +51 | +2.7% | 120,200 |
2020/11/26 | 1,866 | 1,900 | 1,859 | 1,881 | +6 | +0.3% | 46,200 |
2020/11/25 | 1,914 | 1,914 | 1,872 | 1,875 | -15 | -0.8% | 53,600 |
2020/11/24 | 1,917 | 1,924 | 1,875 | 1,890 | +22 | +1.2% | 71,800 |
2020/11/20 | 1,877 | 1,891 | 1,866 | 1,868 | -36 | -1.9% | 79,600 |
2020/11/19 | 1,890 | 1,917 | 1,890 | 1,904 | -4 | -0.2% | 41,300 |
2020/11/18 | 1,901 | 1,925 | 1,893 | 1,908 | -16 | -0.8% | 52,600 |
2020/11/17 | 1,928 | 1,937 | 1,901 | 1,924 | -14 | -0.7% | 59,900 |
2020/11/16 | 1,963 | 1,963 | 1,929 | 1,938 | +14 | +0.7% | 67,700 |
2020/11/13 | 1,967 | 1,967 | 1,921 | 1,924 | -43 | -2.2% | 29,900 |
2020/11/12 | 1,968 | 1,970 | 1,940 | 1,967 | ±0 | ±0% | 43,000 |
2020/11/11 | 1,974 | 1,977 | 1,942 | 1,967 | +30 | +1.5% | 63,200 |
2020/11/10 | 1,914 | 1,954 | 1,914 | 1,937 | +17 | +0.9% | 78,700 |
2020/11/09 | 1,910 | 1,929 | 1,892 | 1,920 | +10 | +0.5% | 55,300 |
2020/11/06 | 1,957 | 1,957 | 1,909 | 1,910 | -51 | -2.6% | 71,200 |
2020/11/05 | 1,867 | 1,963 | 1,845 | 1,961 | +73 | +3.9% | 173,500 |
2020/11/04 | 1,915 | 1,915 | 1,877 | 1,888 | +19 | +1% | 74,000 |
2020/11/02 | 1,864 | 1,899 | 1,856 | 1,869 | +17 | +0.9% | 55,300 |
2020/10/30 | 1,854 | 1,873 | 1,837 | 1,852 | -2 | -0.1% | 50,000 |
2020/10/29 | 1,827 | 1,865 | 1,827 | 1,854 | +9 | +0.5% | 25,900 |
2020/10/28 | 1,832 | 1,846 | 1,822 | 1,845 | -2 | -0.1% | 40,900 |
2020/10/27 | 1,836 | 1,870 | 1,826 | 1,847 | +4 | +0.2% | 27,200 |
2020/10/26 | 1,839 | 1,855 | 1,833 | 1,843 | +3 | +0.2% | 26,600 |
951~
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム